Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
781 Views
eMediNexus 19 January 2018
A meta-regression analysis of 14 clinical trials, published online in the Journal of Bone and Mineral Research, suggests that treatment-related changes in bone formation markers predict vertebral-fracture reduction with anti-resorptive drug therapy. Drugs that prevent and treat osteoporosis are known to cause short-term changes in bone-turnover markers, and these changes have been linked to subsequent fracture reduction in some studies. The results from this analysis could pave way for the development of new osteoporosis treatments or when considering new populations or dosing regimens with existing treatment.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Detecting Intra-abdominal Adhesions in Women with Repeated C-sections..
Maintaining Liver Health to Optimize Glycemic Outcomes in Early Type 2.....
Antibiotic Prescribing Practices for Pediatric Acute Otitis Media..
Hidden Hazard of Indoor Pollution in COPD..
Recognizing Pitfalls of Point-of-Care Lung Ultrasound..
{{Article_Title}}..
Bombay HC Questions Denial of Motherhood to Woman with Intellectual Disability..
HMPV Outbreak in India: Health Minister Warns of Similar Symptoms to COVID-19, States Prepare Special ICU Wards..
Maharashtra Medical Education Minister Warns Children and Elderly to Stay Alert amid HMPV Cases..
Medical Negligence in Rewa: Surgical Needle Left inside Woman's Abdomen for Two Years..
HMPV in India: Seven Cases Reported across Four States..